NeuraMetrix is a pioneering brand in the field of cognitive detection and monitoring digital biomarkers for neurological disorders and psychiatric diseases. Their innovative medical devices offer a novel and highly accurate solution for detecting and monitoring a wide range of conditions such as Parkinson's, Huntington's, depression, and Alzheimer's. Through the use of unique technology, NeuraMetrix enables healthcare professionals, clinics, and patients to effectively detect and monitor brain diseases using typing cadence.

With a team of experienced leaders and a scientific advisory board, NeuraMetrix is dedicated to advancing the field of brain health and improving patient outcomes. Based in Asheville, NC, their headquarters serve as the center for research, development, and innovation. As a medical device company, NeuraMetrix is committed to providing cutting-edge solutions that contribute to the early detection and management of neurological and psychiatric diseases.

Their digital biomarker technology is a game-changer in the field, offering a reliable and non-invasive approach to brain health assessment